Is targeting of CD47-SIRPα enough for treating hematopoietic malignancy?
- PMID: 22555661
- DOI: 10.1182/blood-2011-11-391367
Is targeting of CD47-SIRPα enough for treating hematopoietic malignancy?
Comment on
-
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy.Blood. 2011 Nov 3;118(18):4890-901. doi: 10.1182/blood-2011-02-338020. Epub 2011 Aug 9. Blood. 2011. PMID: 21828138 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials

